Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.52 USD
Change Today 0.00 / 0.00%
Volume 258.4K
ATNM On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at actinium pharmaceuticals inc (ATNM)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Sandesh Seth M.S.,MBA24 RelationshipsExecutive Chairman and Member of Compensation CommitteeTop Key Executive50
Kaushik Dave Ph.D., R.Ph., MBA.17 RelationshipsChief Executive Officer, President, Interim Chief Financial Officer, Principal Accounting Officer and DirectorChief Executive Officer53

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Joseph Jurcic M.D. 17 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
C. Nicholson B.S., Ph.D. 35 RelationshipsMember of the Board of DirectorsActavis plc59
Richard Steinhart MBA 24 RelationshipsMember of the Board of DirectorsAtossa Genetics, Inc.57
Elihu Estey M.D. 17 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
Judith Karp M.D. 25 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
John Pagel M.D., Ph.D. 17 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
Alexander Perl M.D. 17 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
Richard Wahl M.D. 17 RelationshipsMember of Advisory BoardThreshold Pharmaceuticals Inc.--
David Scheinberg M.D., Ph.D. 61 RelationshipsMember of Advisory BoardProgenics Pharmaceuticals, Inc.58
Sergio Traversa PharmD, MBA 24 RelationshipsMember of the Board of DirectorsRelmada Therapeutics, Inc.53
Hagop Kantarjian M.D. 56 RelationshipsMember of Advisory BoardAstex Therapeutics Limited--
Sergio Giralt M.D. 50 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
Hillard Lazarus M.D. 44 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
Peter McSweeney M.D. 17 RelationshipsMember of Advisory BoardRocky Mountain Cancer Centers--
M. Levy M.D. 17 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
Richard Champlin M.D. 55 RelationshipsMember of Advisory BoardActinium Pharmaceuticals, Inc.--
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATNM:US $2.52 USD 0.00

ATNM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ATNM.
View Industry Companies
 

Industry Analysis

ATNM

Industry Average

Valuation ATNM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTINIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.